Patrick Campbell

While chemotherapy with anthracycline and trastuzumab have been linked to cardiotoxicity, new research is suggesting a common cardiovascular medication could help offset some of the negative impact on cardiovascular health in breast cancer patients.

While multiple previous studies have detailed the additional risk of arrhythmias associated with patients who have cancer, new data is shedding light on which forms of cancer carry the greatest risk.

New research is shedding light on national trends in outcomes and predictors of in-hospital mortality for patients undergoing surgical embolectomy for acute pulmonary embolism.

New research is shedding light on the impact pediatric strabismus has on the quality of life of children and their families.

A new Emory University study sheds light on the relationship between mental and cardiovascular health.

A study of 416 hospitalized patients indicates 19.7% suffered cardiac injury, which was also associated with increased ventilation and mortality.

A special edition ACC House Call with Deepak Bhatt, MD, to discuss the results of a meta-analysis looking at ticagrelor and MALE from 2 clinical trials.

A discussion on a study from ACC.20 examining use of a novel genetic risk score to predict VTE in patients with cardiometabolic disease.

Executive Director of Interventional Cardiovascular Programs at Brigham and Women's discusses some research he took part in being presented at this year's conference.

A new study of more than 30k Swedish men is shedding light on associations between early puberty and risk of T2D.

A new review from investigators at Columbia University details topics from common comorbidities to potential treatments.

New data from ACC.20/WCC indicates low birth weight in infants could indicate mothers who are at increased risk of heart failure later in life.

The document, which includes 11 clinical competencies for NPs and PAs, is the first of its kind from the American College of Cardiology.

New research presented at ACC.20/WCC suggests increased protein intake could reduce the risk of atrial fibrillation in older women up to 8%.

Data published in NEJM demonstrate the siRNA agent's ability to lower cholesterol in patients with multiple conditions.

Manesh Patel, MD, of Duke University School of Medicine, discusses what we know about COVID-19 and its impact on cardiovascular health.

New research from ACC.20/WCC suggests taking statins before initiating chemotherapy with anthracycline or trastuzumab could reduce treatment-associated cardiotoxicity.

The Professor of Medicine at Duke University School of Medicine discusses prescribing DOACs and his opinion on a recent meta-analysis in the Annals of Internal Medicine.

New data from ACC.20/WCC is revealing more about the risk of AF associated with various cancer types.

In a show of solidarity, the major cardiology organizations have released statements addressing the topic.

A new meta-analysis found dual therapy was associated with less bleeding events than triple therapy in AF patients after PCI.

New research from an international team of investigators suggests more than 80% of cases have been transmitted by undocumented infections.

New research suggests taking low-dose aspirin could reduce the risk of hepatocellular carcinoma in high-risk patients.

The incoming president of the American College of Physician offers advice on communicating about the realities and myths of coronavirus with patients.

Incoming president of the American College of Physician offers advice on steps clincians should be taking amid the coronavirus outbreak.

Research from investigators at Brigham and Women's Hospital and Sinai Health is shedding new light on the differences in safety and efficacy between the 2 DOACs.

An analysis of dizziness in primary care patients is shedding new light on the potential dangers and risk of mortality associated with different subtypes of dizziness.

The approval marks the fourth type of cancer nivolumab plus ipilimumab has received approval for treating.

The incoming Editor-in-Chief of Stroke discusses what the future of stroke care might look like and his biggest takeaways from ISC 2020.

The approval is the third for the Boehringer Ingelheim-produced therapy and the first from the FDA for treating patients with chronic fibrosing interstitial lung diseases with a progressive phenotype.